RETRACTED: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
Authors:
- You-Cai YiYYYou-Cai Yi
- Rui LiangRLRui Liang
- Jing ZhangJZJing Zhang
- Jin-Shui ZhuJZJin-Shui Zhu
Open Access
- 2 November 2021
- journal article
- retracted article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Dihydroartemisinin (DHA), a well-known antimalarial drug, has been widely investigated for its antitumor effects in multiple malignancies. However, its effects and regulatory mechanisms in colorectal cancer (CRC) are still unproved. In this study, in vitro experiments including CCK8, EdU, Transwell, and flow cytometry analyses and an in vivo tumorigenesis model were conducted to assess the effects of DHA on the bio-behaviors of CRC cells. Additionally, RNA-seq combined with gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses was used to obtain the targets of DHA, and these were verified by molecular docking, qRT-PCR, and Western blotting. As a result, we found that DHA significantly suppressed the proliferation, DNA synthesis, and invasive capabilities and induced cell apoptosis and cell cycle arrest in HCT116, DLD1, and RKO cells in vitro and in vivo. Further analyses indicated that the targets of DHA were predominantly enriched in cell cycle-associated pathways, including CDK1, CCNB1, and PLK1; and DHA could bind with the CDK1/CCNB1 complex and inhibit the activation of CDK1/CCNB1/PLK1 signaling. Moreover, cucurbitacin E, a specific inhibitor of the CDK1/CCNB1 axis, enhanced the inhibitory effects of DHA on DNA synthesis and colony formation in HCT116 and DLD1 cells. In short, DHA could suppress the tumorigenesis and cycle progression of CRC cells by targeting CDK1/CCNB1/PLK1 signaling.Keywords
Funding Information
- School of Medicine, Shanghai Jiao Tong University (20191831)
- National Natural Science Foundation of China (82074161, 81873143)
- Shanghai Science and Technology Development Foundation (21ZR1448700)
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
This publication has 51 references indexed in Scilit:
- Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate CancerScientific Reports, 2017
- Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant WomenThe Journal of Infectious Diseases, 2017
- Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cellsCancer Letters, 2016
- Antiviral Effects of Artesunate on JC Polyomavirus Replication in COS-7 CellsAntimicrobial Agents and Chemotherapy, 2014
- Therapeutic ROS targeting of GADD45γ in the induction of G2/M arrest in primary human colorectal cancer cell lines by cucurbitacin ECell Death & Disease, 2014
- Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin PathwayThe Journal of Immunology, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- The decision to enter mitosis: feedback and redundancy in the mitotic entry networkJournal of Cell Biology, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008